Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | CASP6 | P55212 | 4/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
| ▸ | NSD2 | O96028 | 3/20 | 0.40 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.40 |
| ▸ | PTPN5 | P54829 | 2/20 | 0.40 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.40 |
| ▸ | CASP7 | P55210 | 1/20 | 0.40 |
| ▸ | NT5E | P21589 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.39 |
| ▸ | PTPRA | P18433 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7192766 | 0.83 | CYP2D6 (0.58) | CYP2D6ALDH1A1CASP6CYP2C9CYP2C19 | |
| SCHEMBL6389349 | 0.82 | ALDH1A1 (0.49) | CYP2D6ALDH1A1CASP6CYP2C9CYP2C19 | |
| SCHEMBL7543178 | 0.82 | CYP2D6 (0.56) | CYP2D6ALDH1A1CASP6CYP2C9CYP2C19 | |
| SCHEMBL6390634 | 0.81 | CYP2D6 (0.49) | CYP2D6ALDH1A1CYP2C19HSD17B10MEN1 | |
| SCHEMBL600272 | 0.76 | CDC25B (0.58) | CYP2D6ALDH1A1CYP2C19HSD17B10MEN1 | |
| SCHEMBL4957630 | 0.76 | KDM4E (0.41) | ALDH1A1CYP2C19HSD17B10MEN1KMT2A | |
| SCHEMBL8599488 | 0.75 | ALDH1A1 (0.50) | CYP2D6ALDH1A1CASP6CYP2C9CYP2C19 | |
| SCHEMBL1145407 | 0.75 | ALDH1A1 (0.50) | CYP2D6ALDH1A1CASP6CYP2C9CYP2C19 | |
| SCHEMBL29421128 | 0.75 | ALDH1A1 (0.50) | CYP2D6ALDH1A1CASP6CYP2C9CYP2C19 | |
| SCHEMBL4961121 | 0.75 | ALDH1A1 (0.41) | ALDH1A1CYP2C19HSD17B10MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1551902-B1 | ANISOTROPIC FILMS BASED ON 1,8-NAPHTHOYLENE-1 ,2 -BENZIMIDAZOLE SULFONATES AND LYOTROPIC LIQUID CRYSTAL SYSTEMS AND METHODS FOR MAKING | NITTO DENKO CORP (JP) | 2008-09-10 | — | — | EP | disclosed |
| US-7262305-B2 | Anisotropic films based on 1,8-naphthoylene-1′,2′-benzimidazole sulfonates and lyotropic liquid crystal systems and methods for making | NITTO DENKO CORPORATION (JP) | 2007-08-28 | — | — | US | disclosed |
| EP-1551902-A4 | ANISOTROPIC FILMS BASED ON 1,8-NAPHTHOYLENE-1 ,2 -BENZIMIDAZOLE SULFONATES AND LYOTROPIC LIQUID CRYSTAL SYSTEMS AND METHODS FOR MAKING | NITTO DENKO CORP (JP) | 2006-05-17 | — | — | EP | disclosed |
| US-7026019-B2 | Anisotropic films based on 1,8-naphthoylene-1′,2′-benzimidazole sulfonates and lyotropic liquid crystal systems and methods for making | NITTO DENKO CORPORATION (JP) | 2006-04-11 | — | — | US | disclosed |
| US-20060062932-A1 | Anisotropic films based on 1,8-naphthoylene-1'2'-benzimidazole sulfonates and lyotropic liquid crystal systems and methods for making | DUTOVA TATYANA Y | 2006-03-23 | — | — | US | disclosed |
| EP-1551902-A2 | ANISOTROPIC FILMS BASED ON 1,8-NAPHTHOYLENE-1 ,2 -BENZIMIDAZOLE SULFONATES AND LYOTROPIC LIQUID CRYSTAL SYSTEMS AND METHODS FOR MAKING | Optiva, Inc. (US) | 2005-07-13 | — | — | EP | disclosed |
| US-20040058091-A1 | Anisotropic films based on 1,8-naphthoylene-1',2'-benzimidazole sulfonates and lyotropic liquid crystal systems and methods for making | INSOLVENCY SERVICES GROUP, INC. | 2004-03-25 | — | — | US | disclosed |
| WO-2004003599-A2 | ANISOTROPIC FILMS BASED ON 1,8-NAPHTHOYLENE-1',2'-BENZIMIDAZOLE SULFONATES AND LYOTROPIC LIQUID CRYSTAL SYSTEMS AND METHODS FOR MAKING | OPTIVA, INC. (US) | 2004-01-08 | — | — | WO | disclosed |
| US-4791194-A | DURABILITY; ELECTROGRAPHY | MITSUBISHI CHEMICAL INDUSTRIES, LTD. (JP) | 1988-12-13 | — | — | US | disclosed |
| EP-0150707-B1 | ELECTROPHOTOGRAPHIC PHOTORECEPTOR | MITSUBISHI KASEI CORPORATION (JP) | 1988-04-13 | — | — | EP | disclosed |
| US-4618555-A | PHOTOSENSITIVITY; DURABILITY | MITSUBISHI CHEMICAL IND., LTD. (JP) | 1986-10-21 | — | — | US | disclosed |
| EP-0150707-A1 | Electrophotographic photoreceptor | MITSUBISHI KASEI CORPORATION (JP) | 1985-08-07 | — | — | EP | disclosed |
| US-4204063-A | ANTITUMOR AGENTS | LABORATORIOS MADE, S.A. (ES) | 1980-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060062932-A1 | Anisotropic films based on 1,8-naphthoylene-1'2'-benzimidazole sulfonates and lyotropic liquid crystal systems and methods for making | LSS, LASP1, LYAR | CYP2D6 1649/4885ALDH1A1 2043/4885CASP6 971/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.